Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda H Rodgers

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer|October 29, 2024
Reply to "Expansion of pan-cancer mismatch repair testing: Implications for pembrolizumab eligibility and Lynch syndrome screening"Teresa S Chai, Linda H Rodgers-Fouche, Anthony R Mattia, et al.
Journal of Genetic Counseling|August 9, 2022
Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical centerCaitlin M Finn, Shelley McCormick, Danielle Peterson, et al.
Journal of Genetic Counseling|December 5, 2020
Transition to telephone genetic counseling services during the COVID-19 pandemicKristen M Shannon, Margaret M Emmet, Linda H Rodgers, et al.
Journal of Genetic Counseling|June 21, 2018
Finding a Balance: Reconciling the Needs of the Institution, Patient, and Genetic Counselor for Optimal Resource UtilizationDevanshi Patel, Erica L Blouch, Linda H Rodgers-Fouché, et al.
Journal of Medical Genetics|May 6, 2019
Gastric cancer in Lynch syndrome is associated with underlying immune gastritisTomer Adar, Madeline Friedman, Linda H Rodgers, et al.
Diseases of the Colon and Rectum|February 11, 2025
Cancer Incidence and Mortality in Familial Adenomatous Polyposis SyndromeDan Feldman, Linda H Rodgers-Fouche, Chinedu Ukaegbu, et al.
Cancer Genetics|October 4, 2011
Which individuals undergoing BRACAnalysis need BART testing?Kristen M Shannon, Linda H Rodgers, Gayun Chan-Smutko, et al.
Cancer|July 18, 2024
Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiencyTeresa S Chai, Linda H Rodgers-Fouche, Jenna O Walls, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndromeTomer Adar, Linda H Rodgers, Kristen M Shannon, et al.
European Urology Oncology|March 7, 2024
Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening StudyAndrew E Amini, Alexandra E Hunter, Aya Almashad, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer|October 29, 2024
Reply to "Expansion of pan-cancer mismatch repair testing: Implications for pembrolizumab eligibility and Lynch syndrome screening"Teresa S Chai, Linda H Rodgers-Fouche, Anthony R Mattia, et al.
Journal of Genetic Counseling|August 9, 2022
Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical centerCaitlin M Finn, Shelley McCormick, Danielle Peterson, et al.
Journal of Genetic Counseling|December 5, 2020
Transition to telephone genetic counseling services during the COVID-19 pandemicKristen M Shannon, Margaret M Emmet, Linda H Rodgers, et al.
Journal of Genetic Counseling|June 21, 2018
Finding a Balance: Reconciling the Needs of the Institution, Patient, and Genetic Counselor for Optimal Resource UtilizationDevanshi Patel, Erica L Blouch, Linda H Rodgers-Fouché, et al.
Journal of Medical Genetics|May 6, 2019
Gastric cancer in Lynch syndrome is associated with underlying immune gastritisTomer Adar, Madeline Friedman, Linda H Rodgers, et al.
Diseases of the Colon and Rectum|February 11, 2025
Cancer Incidence and Mortality in Familial Adenomatous Polyposis SyndromeDan Feldman, Linda H Rodgers-Fouche, Chinedu Ukaegbu, et al.
Cancer Genetics|October 4, 2011
Which individuals undergoing BRACAnalysis need BART testing?Kristen M Shannon, Linda H Rodgers, Gayun Chan-Smutko, et al.
Cancer|July 18, 2024
Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiencyTeresa S Chai, Linda H Rodgers-Fouche, Jenna O Walls, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndromeTomer Adar, Linda H Rodgers, Kristen M Shannon, et al.
European Urology Oncology|March 7, 2024
Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening StudyAndrew E Amini, Alexandra E Hunter, Aya Almashad, et al.
Pageof 2